EHI
PRCT icon

Eagle Health Investments’s Procept Biorobotics PRCT Stock Holding History

Eagle Health Investments’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-90,000
Closed -$2.25M – 30
2026
Q1 		$2.25M Buy
+90,000
New +$2.54M 0.39% 25

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Eagle Health Investments's PRCT Position: Q2 2026 in Review

Eagle Health Investments sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 483,815 shares — an estimated $12.1M sold.

Eagle Health Investments first reported a position in PRCT in Q1 2023 and held it in 13 quarters. The position peaked at $18.8M in Q4 2024. 105 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Eagle Health Investments reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Eagle Health Investments sold 483,815 Procept Biorobotics shares in Q2 2026, an estimated $12.1M.
  • Eagle Health Investments first reported a position in Procept Biorobotics in Q1 2023 and held it in 13 quarters.
  • Eagle Health Investments's Procept Biorobotics position peaked at $18.8M in Q4 2024.
  • 105 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Eagle Health Investments's 13F filing for Q2 2026, filed 10 Aug 2026.